Metraipolis › archive › dc_64be9681198a
Bisphenol S and Epidermal Growth Factor Receptor Signaling in Human Placental Cytotrophoblasts — Europe PMC PMID:33605785
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/33605785
- DOI
- 10.1289/ehp7297
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-05T20:59:30.701Z
- SHA-256 of the archived text
e37f404f8fc349199544fda9f1546bbe38305ae9dbc099a357299ca697895656- Stable URL of this page
https://metraipolis.com/documento/dc_64be9681198a
How to cite
Bisphenol S and Epidermal Growth Factor Receptor Signaling in Human Placental Cytotrophoblasts — Europe PMC PMID:33605785 — Europe PMC (en), https://europepmc.org/article/MED/33605785 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_64be9681198a (Metraipolis archive dc_64be9681198a, sha256 e37f404f8fc349199544fda9f1546bbe38305ae9dbc099a357299ca697895656)
BibTeX
@misc{dc64be9681198a,
title = {Bisphenol S and Epidermal Growth Factor Receptor Signaling in Human Placental Cytotrophoblasts — Europe PMC PMID:33605785},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/33605785},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_64be9681198a; sha256 e37f404f8fc349199544fda9f1546bbe38305ae9dbc099a357299ca697895656},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33605785. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: Bisphenol S (BPS) is an endocrine-disrupting chemical and the second most abundant bisphenol detected in humans. In vivo BPS exposure leads to reduced binucleate cell number in the ovine placenta. Binucleate cells form by cellular fusion, similar to the human placental syncytiotrophoblast layer. Given that human placental syncytialization can be stimulated through epidermal growth factor (EGF), we hypothesized that BPS would reduce human cytotrophoblast syncytialization through disruption of EGF receptor (EGFR) signaling. Objective: We tested whether BPS interferes EGFR signaling and disrupts human cytotrophoblast syncytialization. Methods: We first tested BPS competition for EGFR using an EGF/EGFR AlphaLISA assay. Using human primary term cytotrophoblast cells (hCTBs) and MDA-MD-231 cells, a breast cancer cell line with high EGFR expression, we evaluated EGFR downstream signaling and tested whether BPS could inhibit the EGF response by blocking EGFR activation. We also evaluated functional end points of EGFR signaling, including EGF endocytosis, cell proliferation, and syncytialization. Results: BPS blocked EGF binding in a dose-dependent manner and reduced EGF-mediated phosphorylated EGFR in both cell types. We further confirmed that BPS acted as an EGFR antagonist as shown by a reduction in EGF internalization in both hCTBs and MDA-MD-231 cells. Finally, we demonstrated that BPS interfered with EGF-mediated cell processes, such as cell proliferation in MDA-MD-231 cells and syncytialization in hCTBs. EGF-mediated, but not spontaneous, hCTB syncytialization was fully blocked by BPS (200 ng/mL), a dose within urinary BPS concentrations detected in humans. Conclusions: Given the role of EGFR in trophoblast proliferation and differentiation during placental development, this study suggests that exposures to BPS at environmentally relevant concentrations may result in placenta dysfunction, affecting fetal growth and development. https://doi.org/10.1289/EHP7297. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: Environmental health perspectives, 2021 (prima pubblicazione 2021-02-19). Identificativi: PMID 33605785 · PMCID PMC7894408 · DOI 10.1289/ehp7297. Descrittori MeSH principali: Trophoblasts; Placenta. Pagina: https://europepmc.org/article/MED/33605785 — https://doi.org/10.1289/ehp7297. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-05T20:48:23.108Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.